‘Case-mix models for home health care payment’ in Health Policy
Case-mix based payment of health care services offers potential to contain expenditure growth and simultaneously support needs-based care provision. However, limited evidence exists on its application in home health care (HHC). Therefore, this study aimed to synthesize available international literature on existing case-mix models for HHC payment.
We performed a systematic review of scientific literature, supplemented with grey literature. We searched for literature using six scientific databases, reference lists, expert consultation, and targeted websites. Data on study design, case-mix model attributes, and conclusions were extracted narratively. Of 3,303 references found, 22 scientific studies and 27 grey documents met eligibility criteria.
Eight case-mix models for HHC were identified, from the US, Canada, New Zealand, Australia, and Germany. Three countries have implemented a case-mix model as part of a HHC payment system. Different combinations of in total 127 unique case-mix predictors are included across models to predict HHC use. Case-mix models also differ in targeted services, operationalization, and outcome measures and predictive power. Case-mix based payment is not yet widely used within HHC. Multiple varieties were found between HHC case-mix models, and no one best form of a model seems to exist. Even though varieties are partly inevitable due to country-specific contexts, developing a shared vision in case-mix model attributes would be key to achieving efficient, needs-based HHC.
By Anne van den Bulck, Maud de Korte, Arianne Elissen, Silke Metzelthin, Misja Mikkers and Dirk Ruwaard
For more information, see Health Policy https://doi.org/10.1016/j.healthpol.2019.12.012
Also read
-
Invisible protectors: how bacteria from nature can prevent allergies
In this video, Niels van Best explains his research on how bacteria from nature can strengthen the immune system of young infants.
-
Nationwide project for animal-free biomedical research on osteoarthritis launched
Tim Welting (CAPHRI) and his team will develop human cell-based models to accelerate development of osteoarthritis medication.
-
Study Smart gets Dutch Education Premium
Maastricht University's (UM) interfaculty educational innovation project Study Smart is one of the three winners of the Dutch Education Premium 2025. This was announced on Tuesday during the Comenius festival in The Hague.